ABOUT
CELLTELLIGENCE

Celltelligence is a unique mix of industry experts, analysts, and academics dedicated to bringing deeper context and insight to the cell therapy market. Here’s why we’re different.

ABOUT
CELLTELLIGENCE

Celltelligence is a unique mix of industry experts, analysts, and academics dedicated to bringing deeper context and insight to the cell therapy market. Here’s why were different.

WHO WE ARE

Our team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.

WHO WE ARE

Our team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.

WHY WE’RE DIFFERENT

Celltelligence isn’t just another newsletter or curated content blast. Our market intelligence is heavily researched, up-to-date, and deeply informed by our direct relationships with cell therapy stakeholders including KOLs. This provides our customers with an insider’s perspective on the market, helping you to create more accurate forecasts and quicker calculated decisions.

WHY WE’RE DIFFERENT

Celltelligence isn’t just another newsletter or curated content blast. Our market intelligence is heavily researched, up-to-date, and deeply informed by our direct relationships with cell therapy stakeholders including KOLs. This provides our customers with an insider’s perspective on the market, helping you to create more accurate forecasts and quicker calculated decisions.

HOW WE MAKE YOUR JOB EASIER

The Blast, Map, and Library are all designed for people who care about cell therapy and want better, easier options to leverage market insight. We tailor content to all relevant stakeholders – including industry professionals, academics, and both buy- and sell-side analysts. With Celltelligence, you’ll make it easier to uncover blindspots and stay on top of industry movement for your organization or your clients.

HOW WE MAKE YOUR JOB EASIER

The Blast, Map, and Library are all designed for people who care about cell therapy and want better, easier options to leverage market insight. We tailor content to all relevant stakeholders – including industry professionals, academics, and both buy- and sell-side analysts. With Celltelligence, you’ll make it easier to uncover blindspots and stay on top of industry movement for your organization or your clients.

MEET THE ‘TELLIGENCE IN OUR TEAM

Matthew Maryniak
Team Lead
  • Co-founder & President of Fenix Group International, LLC, a global life sciences consulting firm parent company of Celltelligence (2015-present)
  • Former Principal at IQVIA Consulting Group (8 years tenure)
  • Recognized industry expert in Pink Sheet, PM360, and journal article
  • MBA in Pharmaceutical Business, Univ of Sciences in PHL
Mark McCully, PhD
Senior Content Lead
  • Project Lead at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2018-present)
  • 10+ years experience in oncology and cell therapies
  • Marie Curie COFUND fellow (oncology), IRB Barcelona
  • PhD in Nanomedicine, Univ of Glasgow
Antonio Marti Polo, MSc
Content Contributor
  • Senior Analyst at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2020-present)
  • BSc in Biochemistry and Molecular biology, Benedictine University
  • MSc in Pharmaceutical and Biotechnological Industry, Universitat Pompeu Fabra
  • MBA in Business Administration and Management, ThePowerMBA
Kelly Leon, PhD
Content Contributor
  • Consultant at Fenix Group International, LLC, and Celltelligence contributor (2021-present)
  • 4+ years of academic research focusing on the epigenetic reprogramming occurring during cellular senescence and its contribution to tumorigenesis
  • PhD Biomedical Sciences, Penn State University – College of Medicine
  • BS Biochemistry and Molecular Biology, Penn State University – Berks
Erik Oliemuller García, PhD
Content Contributor
  • Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2021-present)
  • 10+ years experience in clinical and translational research in oncology at international academic institutes
  • PhD in Cellular and Molecular Biology, Universidad de Navarra
  • BSc in Biochemistry, Universidad de Navarra
  • BSc in Biology, Universidad de Navarra
Adrián Ramón Santonja, MSc
Content Contributor
  • Senior Analyst at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • Innovation Consultant, University of Copenhagen
  • MSc Molecular Biomedicine, University of Copenhagen
  • BSc Biomedicine, Autonomous University of Barcelona
Gerard Robinson, PhD
Content Contributor
  • Consultant at Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • 6+ years experience in academic research developing and working with preclinical models of cytokine signaling, pathogen sensing, and acute phase proteins in skeletal muscle
  • PhD, Exercise Physiology, University of Florida
  • MS, Human Performance, University of Florida
  • BS, Applied Physiology, University of Florida
Federico Bech Díaz, PhD
Content Contributor
  • Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • 8+ years experience in Research in Oncology and Neuroscience, with several high-impact journal publications and participation in international congresses
  • PhD Health Science, University of Oviedo
  • MSs in “Medical Affairs, Medical Advisor and Medical Scientific Liaison”, Talento Farmaceutico-Ephos/ Universidad Europea
  • MSc in Biomedicine and Molecular Oncology, University of Oviedo
  • BSc in Biology, University of Oviedo
Dale Friel
Content Contributor
  • Analyst at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • Research assistant – Metabolomics lab at NUI Galway, Ireland
  • BS Biomedical Science (Physiology) from the National University of Ireland, Galway
Anirudh Lingamaneni, MD
Content Contributor
  • Consultant at Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • 5+ years experience working in the healthcare field throughout school and professional career
  • MD, Avalon University

MEET THE ‘TELLIGENCE IN OUR TEAM

Matthew Maryniak
Team Lead
  • Co-founder & President of Fenix Group International, LLC, a global life sciences consulting firm parent company of Celltelligence (2015-present)
  • Former Principal at IQVIA Consulting Group (8 years tenure)
  • Recognized industry expert in Pink Sheet, PM360, and journal article
  • MBA in Pharmaceutical Business, Univ of Sciences in PHL
Mark McCully, PhD
Senior Content Lead
  • Project Lead at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2018-present)
  • 10+ years experience in oncology and cell therapies
  • Marie Curie COFUND fellow (oncology), IRB Barcelona
  • PhD in Nanomedicine, Univ of Glasgow
Antonio Marti Polo, MSc
Content Contributor
  • Senior Analyst at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2020-present)
  • BSc in Biochemistry and Molecular biology, Benedictine University
  • MSc in Pharmaceutical and Biotechnological Industry, Universitat Pompeu Fabra
  • MBA in Business Administration and Management, ThePowerMBA
Kelly Leon, PhD
Content Contributor
  • Consultant at Fenix Group International, LLC, and Celltelligence contributor (2021-present)
  • 4+ years of academic research focusing on the epigenetic reprogramming occurring during cellular senescence and its contribution to tumorigenesis
  • PhD Biomedical Sciences, Penn State University – College of Medicine
  • BS Biochemistry and Molecular Biology, Penn State University – Berks
Erik Oliemuller García, PhD
Content Contributor
  • Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2021-present)
  • 10+ years experience in clinical and translational research in oncology at international academic institutes
  • PhD in Cellular and Molecular Biology, Universidad de Navarra
  • BSc in Biochemistry, Universidad de Navarra
  • BSc in Biology, Universidad de Navarra
Adrián Ramón Santonja, MSc
Content Contributor
  • Senior Analyst at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • Innovation Consultant, University of Copenhagen
  • MSc Molecular Biomedicine, University of Copenhagen
  • BSc Biomedicine, Autonomous University of Barcelona
Gerard Robinson, PhD
Content Contributor
  • Consultant at Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • 6+ years experience in academic research developing and working with preclinical models of cytokine signaling, pathogen sensing, and acute phase proteins in skeletal muscle
  • PhD, Exercise Physiology, University of Florida
  • MS, Human Performance, University of Florida
  • BS, Applied Physiology, University of Florida
Federico Bech Díaz, PhD
Content Contributor
  • Consultant at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • 8+ years experience in Research in Oncology and Neuroscience, with several high-impact journal publications and participation in international congresses
  • PhD Health Science, University of Oviedo
  • MSs in “Medical Affairs, Medical Advisor and Medical Scientific Liaison”, Talento Farmaceutico-Ephos/ Universidad Europea
  • MSc in Biomedicine and Molecular Oncology, University of Oviedo
  • BSc in Biology, University of Oviedo
Dale Friel
Content Contributor
  • Analyst at FGI Life Sciences, SL, part of Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • Research assistant – Metabolomics lab at NUI Galway, Ireland
  • BS Biomedical Science (Physiology) from the National University of Ireland, Galway
Anirudh Lingamaneni, MD
Content Contributor
  • Consultant at Fenix Group International, LLC, and Celltelligence contributor (2022-present)
  • 5+ years experience working in the healthcare field throughout school and professional career
  • MD, Avalon University

START TODAY FOR FREE

Get contextualized, actionable insights on the cell therapy landscape and all its players delivered to your inbox weekly.

SIGN UP FREE

Copyright © 2022 Fenix Group International, LLC